Company / R&D per Share
Dare Bioscience, Inc. R&D per Share History
FY2014-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D per Share
$1.64
FY2025
5-year range
$0.35 / $2.59
FY2021-FY2025
Trend
-36.4%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from $0.35 to $1.64 over the past 2 years.
Based on SEC 10-K filings.
1.64 in FY2025 with a 10-year CAGR of +13.1%.
Improved from $0.35 to $1.64 over the past 2 years.
R&D per Share over time
Growth rates
- 3-Year CAGR
- +65.2%
- 5-Year CAGR
- -
- 10-Year CAGR
- +13.1%
Key checks
Key Insights
- In FY2025, r&d per share decreased 36.4% year-over-year.
- Peak r&d per share was recorded in FY2014.
- Lowest r&d per share in the period was in FY2023.
Company context
Key Data Points
- Altman Z-Score -2.23 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | R&D per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.64 | -36.4% |
| FY2024 | $2.59 | +630.0% |
| FY2023 | $0.35 | -2.9% |
| FY2022 | $0.36 | -15.3% |
| FY2016 | $0.43 | -10.7% |
| FY2015 | $0.48 | -97.6% |
| FY2014 | $20.12 | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026